Condition

Diabetes Mellitus, Type 1 (2)

Autoimmunity (1)

Diabetes, Type I (1)

Enterovirus Infections (1)

Type 1 Diabetes Mellitus (1)

Overall Status

Completed (3)

Terminated (1)

Phase

phase 2 (3)

phase 1 (1)

Sponsor

Johnny Ludvigsson (2)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Oslo University Hospital (1)

Collaborator

Diamyd Medical AB (2)

Ostergotland County Council, Sweden (2)

Swedish Child Diabetes Foundation (2)

American Diabetes Association (1)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Juvenile Diabetes Research Foundation (1)

National Center for Research Resources (NCRR) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Intervention

gad-alum (4)

vitamin d (2)

aluminum hydroxide (1)

etanercept (1)

gad-alum and aluminum hydroxide (1)

placebo (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (4)

gad-alum

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)

Completed

Has Results

Diabetes Mellitus, Type 1

GAD-Alum
+2 more

Helsingborg, Sweden
+7 more

Mar 26, 2021

Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)

Completed

Has Results

Diabetes Mellitus, Type 1

GAD-Alum
Vitamin D

Linköping, Sweden

Linköping University

Apr 15, 2020

Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

Completed

Has Results

Type 1 Diabetes Mellitus

GAD-Alum
+2 more

Los Angeles, California
+14 more

Apr 27, 2020

Diabetes, Type I, Enterovirus Infections, Autoimmunity Trial in Oslo (GAD-alum, Placebo)

Terminated

Diabetes, Type I
+2 more

GAD-alum
Placebo

Oslo, Norway

Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker

May 14, 2018